EDIT vs IBM · rev $32.3M vs P/E 25, rev $67.53B
Editas Medicine Inc (EDIT) versus International Business Machines (IBM) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
International Business Machines (IBM) is a information technology services company listed on US. It is led by Arvind Krishna.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported IBM revenue for 2025-12-31 was $67.53B. Net income was $10.59B. Revenue was up 7.6% from 2024-12-31 to 2025-12-31. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
EDIT currently screens at market cap $375.2M. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
Not investment advice. Open the EDIT and IBM stock pages for the full models.
Not investment advice.